Anti-HIF-1 alpha antibody [EPR16897-145]
- 20ul selling size
- RabMAb
- Advanced Validation
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(16 Publications)
Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) is a rabbit monoclonal antibody detecting HIF-1 alpha in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, ICC/IF, ChIP. Suitable for Human, Mouse.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
BHLHE78, MOP1, PASD8, HIF1A, Hypoxia-inducible factor 1-alpha, HIF-1-alpha, HIF1-alpha, ARNT-interacting protein, Basic-helix-loop-helix-PAS protein MOP1, Class E basic helix-loop-helix protein 78, Member of PAS protein 1, PAS domain-containing protein 8, bHLHe78
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HeLa (human cervical adenocarcinoma epithelial cell) cells labelling HIF-1 alpha with ab308433 at 1/100 (5.125 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal images showing nuclear staining in HeLa cells treated with DFO (0.5 mM) for 24 hours and showing no staining in untreated HeLa cells.Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HIF1A KO HCT 116 (HIF1A knockout human colorectal carcinoma epithelial cell), ab255394 cells labelling HIF-1 alpha with ab308433 at 1/100 (10.25 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal images showing nuclear staining in wildtype HCT 116 cells treated with DFO (0.5mM) for 24 hours and showing no staining in HIF1A knockout HCT 116 cells treated with the same condition.Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized HeLa (human cervical adenocarcinoma epithelial cell) treated with 0.5mM DFO for 24h (Red) / untreated HeLa (Green) cells labelling HIF-1 alpha with ab308433 at 1/50 dilution (1 ug)/Red and Green (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
- ChIP-seq
Supplier Data
ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.
- IP
Supplier Data
Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
HIF-1 alpha was immunoprecipitated from 0.35 mg HCT116 (human colorectal carcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate with ab308433 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab308433 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : HCT116 (human colorectal carcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate
Lane 2 : ab308433 IP in HCT116 (human colorectal carcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab308433 in HCT116 treated with 0.5 mM DFO for 24 hour whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 15 seconds
All lanes:
Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) at 1/1000 dilution
All lanes:
HCT116 (human colorectal carcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 110 kDa
false
Exposure time: 15s
- ChIP
Supplier Data
ChIP - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Chromatin was prepared from HeLa (human cervical adenocarcinoma epithelial cell) treated with DFO(0.5mM 24h) and HeLa non-treated according to the Abcam Dual-X-ChIP protocol*. Cells were fixed with 1.5 mM EGS for 30mins and then formaldehyde for 10min. The ChIP was performed with 25 µg of chromatin, 5 µg of ab308433 (red), or 5 µg of rabbit normal IgG ab172730 (gray) and 25 µl of Protein A/G Dynabeads. The immunoprecipitated DNA was quantified by real time PCR (Sybr green approach). Primers are from paper PMID : 28193910, 21447827 *Abcam Dual-X-ChIP protocol link
- ChIP-seq
Supplier Data
ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.
- ChIP-seq
Supplier Data
ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.
- IP
Supplier Data
Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
HIF-1 alpha was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate with ab308433 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab308433 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : HeLa (human cervix adenocarcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate
Lane 2 : ab308433 IP in HeLa (human cervix adenocarcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab308433 in HeLa treated with 0.5 mM DFO for 24 hour whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds
All lanes:
Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) at 1/1000 dilution
All lanes:
HeLa (human cervix adenocarcinoma epithelial cell) treated with 0.5 mM DFO for 24 hour whole cell lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 110 kDa
false
Exposure time: 10s
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized bEnd.3 (mouse brain endothelial cell) cells labelling HIF-1 alpha with ab308433 at 1/100 (5.125 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal images showing nuclear staining in bEnd.3 cells treated with DFO (2 mM) for 24 hours and showing no staining in untreated bEnd.3 cells.Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized bEND.3 (mouse brain endothelial cell) treated with 2mM DFO for 24h (Red) / untreated bEND.3 (Green) cells labelling HIF-1 alpha with ab308433 at 1/50 dilution (1 ug)/Red and Green (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
- WB
Supplier Data
Western blot - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.#Lysates/proteins at 20 µg per lane. Performed under reducing conditions. In Western blot, ab308433 was shown to bind specifically to HIF-1 alpha. A band was observed at 110 kDa in wild-type HCT116 cell lysates with whereas no signal observed at this size in HIF-1 alpha knockout cell line ab255394 (knockout cell lysate). The expression of HIF-1 alpha is upregulated in response to DFO treatment (PMID : 25075254). In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution. Lysates were freshly made and used for Western blotting immediately to minimize protein degradation. Exposure time : 180 seconds.
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) at 1/1000 dilution
Lane 1:
Untreated HCT116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HCT116 treated with 0.5 mM DFO for 24 hour whole cell lysate at 20 µg
Lane 3:
Untreated HIF-1 alpha knockout HCT116 whole cell lysate at 20 µg
Lane 4:
HIF-1 alpha knockout HCT116 treated with 0.5 mM DFO for 24 hour whole cell lysate at 20 µg
Lane 5:
Untreated bEnd.3 (mouse brain endothelioma) whole cell lysate at 20 µg
Lane 6:
bEnd.3 treated with 0.5 mM DFO for 24 hour whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 92 kDa
Observed band size: 110 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression of HIF-1 alpha is upregulated in response to DFO treatment (PMID : 25075254).
In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) at 1/1000 dilution
Lane 1:
Untreated HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa treated with 0.5 mM DFO for 24 hour whole cell lysate, at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 92 kDa
Observed band size: 110 kDa
true
Exposure time: 180s
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with CoCl2 (350µM 20h+4h) add MG-132(10µM 4h) and 5 µg of ab308433 [EPR16897-145]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with CoCl2 (350µM 20h+4h) add MG-132(10µM 4h) and 5 µg of ab308433 [EPR16897-145]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EPR16897-145] (AB308433)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with CoCl2 (350µM 20h+4h) add MG-132(10µM 4h) and 5 µg of ab308433 [EPR16897-145]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
Related conjugates and formulations (1)
-
Anti-HIF-1 alpha antibody [EPR16897-145] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF), ChIP in Human, Mouse samples.
What is the molecular weight of HIF-1 alpha?
Anti-HIF-1 alpha [EPR16897-145] (ab308433) specifically detects a band for HIF-1 alpha (UniProt: Q16665) at a molecular weight of 92kDa.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-HIF-1 alpha antibody [EPR16897-145] (ab308433) has been confirmed by Immunocytochemistry/ Immunofluorescence testing in HIF1A Knockout HCT 116 cell line, ab255394.
Other related products
We have a range of other formats of antibody clone [EPR16897-145] also available for your convenience: ab308433, Carrier free - ab308434
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HIF-1 alpha regulates gene expression in response to hypoxic conditions in cells. It forms a complex with HIF-1 beta to activate transcription of various genes involved in energy metabolism angiogenesis and erythropoiesis. HIF-1 alpha enables cells to adapt to reduced oxygen availability allowing for cellular survival and function under stress. It plays an important role in promoting the expression of genes like VEGF and EPO which are important for vascular and red blood cell development respectively.
Pathways
HIF-1 alpha plays an integral role in the hypoxia signaling pathway and the glycolytic pathway. In the hypoxia signaling pathway HIF-1 alpha partners with VHL (Von Hippel-Lindau) protein that regulates its degradation under normal oxygen conditions. When oxygen levels drop HIF-1 alpha avoids degradation stabilizes and translocates into the nucleus to initiate transcription of hypoxia-responsive genes. The glycolytic pathway involvement highlights its function in adapting energy production under hypoxic conditions through collaboration with enzymes and transporters associated with glycolysis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (16)
Recent publications for all applications. Explore the full list and refine your search
Materials today. Bio 35:102306 PubMed41019494
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 29:e70703 PubMed40629256
2025
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 20:e0325936 PubMed40601668
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:5263 PubMed40480985
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 29:e70598 PubMed40387552
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:149 PubMed40032849
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 29:e70382 PubMed39993966
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2412282 PubMed39887620
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 25:35 PubMed39780116
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular biology (Noisy-le-Grand, France) 70:85-91 PubMed38836676
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com